We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Drug Screen Identifies Niclosamide and Ciclesonide As Antiviral Candidates Against SARS-CoV-2

News   May 05, 2020 | Original story from American Society for Microbiology

 
Drug Screen Identifies Niclosamide and Ciclesonide As Antiviral Candidates Against SARS-CoV-2
 
 
Advertisement
 

RELATED ARTICLES

Women Taking Vitamin Supplements May Have Slightly Lower Risk of SARS-CoV-2 Infection

News

A new observational study published in BMJ Nutrition has analyzed self-reported data from the COVID-19 Symptom Study on dietary supplement usage in the first wave of the COVID-19 pandemic. The results suggest a modest association between use of multivitamin, probiotic, omega-3 fatty acid or vitamin D supplements and lower risk of testing positive for SARS-CoV-2 in women.

READ MORE

Infant Allergies Impacted by Their Mode of Birth

News

Researchers have reported a causal link between cesarean section birth, low intestinal microbiota and peanut sensitivity in infants.

READ MORE

New Catalyst for Asymmetric Synthesis of Aziridine Aids Development of Novel Drugs

News

Researchers have been able to obtain aziridine-oxazolone compounds in high yields (99%) as well as high enantioselectivity or purity (98%) using a new catalyst.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE